Cargando…

β(6)-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma

INTRODUCTION: Despite enormous efforts during the past decades, pancreatic adenocarcinoma (PAC) remains one of the most deleterious cancer entities. A useful biomarker for early detection or prognosis of PAC does not yet exist. The goal of our study was the characterization of β(6)-integrin (ITGB6)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenggenhager, Daniela, Bengs, Susan, Fritsch, Ralph, Hussung, Saskia, Busenhart, Philipp, Endhardt, Katharina, Töpfer, Antonia, The, Frans Olivier, Bütikofer, Simon, Gubler, Christoph, Scharl, Michael, Morell, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367066/ https://www.ncbi.nlm.nih.gov/pubmed/34388137 http://dx.doi.org/10.14309/ctg.0000000000000395

Ejemplares similares

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
por: Braun, Lukas M., et al.
Publicado: (2020)

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer
por: Akhoundova, Dilara, et al.
Publicado: (2022)

Efficient treatment of esophageal nutrition bezoars: dissolution outmatches removal—the Zurich approach
por: Morell, Bernhard, et al.
Publicado: (2021)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)

Value of histomorphometric tumour thickness and smoothelin for conventional m-classification in early oesophageal adenocarcinoma
por: Endhardt, Katharina, et al.
Publicado: (2017)

Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
por: Busenhart, Philipp, et al.
Publicado: (2022)

Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
por: Hussung, Saskia, et al.
Publicado: (2021)

Humanized β2 Integrin-Expressing Hoxb8 Cells Serve as Model to Study Integrin Activation
por: Bromberger, Thomas, et al.
Publicado: (2022)

Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer
por: Manz, Salomon M., et al.
Publicado: (2021)

Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker
por: Lu, Ling, et al.
Publicado: (2019)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

The High Expression of Adhering and Circulating Integrin Serves as a Diagnostic Marker in Venous Thromboembolism
por: Yang, Fan, et al.
Publicado: (2022)

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
por: Catalano, Antonella, et al.
Publicado: (2021)

Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?
por: Cefalì, Marco, et al.
Publicado: (2023)

Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance
por: Hering, Larissa, et al.
Publicado: (2020)

Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma
por: Li, Zequn, et al.
Publicado: (2016)

Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma
por: Boroumand-Noughabi, Samaneh, et al.
Publicado: (2010)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

Time-dependent partial differential equations and their numerical solution
por: Kreiss, Heinz Otto, et al.
Publicado: (2001)

Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma
por: Denadai, Marcos VA, et al.
Publicado: (2013)

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
por: Kemper, Marius, et al.
Publicado: (2021)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
por: Wehrle, Julius, et al.
Publicado: (2020)

Pre-Emptive Endoluminal Negative Pressure Therapy at the Anastomotic Site in Minimally Invasive Transthoracic Esophagectomy (the preSPONGE Trial): Study Protocol for a Multicenter Randomized Controlled Trial
por: Müller, Philip C., et al.
Publicado: (2021)

The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2020)

PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18
por: Tang, Jie, et al.
Publicado: (2020)

Correction to: SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma
por: Jin, Xiangfeng, et al.
Publicado: (2021)

SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Liu, Gaohua, et al.
Publicado: (2022)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer
por: Steiner, Sabrina, et al.
Publicado: (2022)

Ligand-independent integrin β1 signaling supports lung adenocarcinoma development
por: Haake, Scott M., et al.
Publicado: (2022)

Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma
por: Damanakis, Alexander I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jknsekkoph5n7grebqp376mpse